ZSCAN4 and head and neck squamous cell carcinoma: While the current acceptable treatment paradigms for HNSCC include surgery with or without radiation therapy or chemotherapy, our data suggests that additional targeted inhibition of ZSCAN4 may function synergistically to enhance treatment efficacy.